1. Home
  2. FNA vs SYRE Comparison

FNA vs SYRE Comparison

Compare FNA & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNA
  • SYRE
  • Stock Information
  • Founded
  • FNA 2010
  • SYRE 2013
  • Country
  • FNA United States
  • SYRE United States
  • Employees
  • FNA N/A
  • SYRE N/A
  • Industry
  • FNA Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • FNA Health Care
  • SYRE Health Care
  • Exchange
  • FNA Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • FNA 910.9M
  • SYRE 897.9M
  • IPO Year
  • FNA 2021
  • SYRE 2016
  • Fundamental
  • Price
  • FNA $13.09
  • SYRE $12.67
  • Analyst Decision
  • FNA Hold
  • SYRE Buy
  • Analyst Count
  • FNA 6
  • SYRE 8
  • Target Price
  • FNA $14.50
  • SYRE $50.00
  • AVG Volume (30 Days)
  • FNA 2.9M
  • SYRE 899.5K
  • Earning Date
  • FNA 05-07-2025
  • SYRE 05-08-2025
  • Dividend Yield
  • FNA N/A
  • SYRE N/A
  • EPS Growth
  • FNA N/A
  • SYRE N/A
  • EPS
  • FNA N/A
  • SYRE N/A
  • Revenue
  • FNA $256,182,000.00
  • SYRE N/A
  • Revenue This Year
  • FNA $14.88
  • SYRE N/A
  • Revenue Next Year
  • FNA $13.92
  • SYRE N/A
  • P/E Ratio
  • FNA N/A
  • SYRE N/A
  • Revenue Growth
  • FNA 18.39
  • SYRE N/A
  • 52 Week Low
  • FNA $4.65
  • SYRE $10.91
  • 52 Week High
  • FNA $13.13
  • SYRE $40.49
  • Technical
  • Relative Strength Index (RSI)
  • FNA 64.55
  • SYRE 36.18
  • Support Level
  • FNA $12.98
  • SYRE $12.04
  • Resistance Level
  • FNA $13.07
  • SYRE $13.29
  • Average True Range (ATR)
  • FNA 0.06
  • SYRE 1.27
  • MACD
  • FNA -0.01
  • SYRE 0.01
  • Stochastic Oscillator
  • FNA 86.67
  • SYRE 26.02

About FNA Paragon 28 Inc.

Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of its revenue from the United States.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. A range of pharmaceutical options to address IBD exists, including anti-inflammatory drugs, immunosuppressants, and biologics.

Share on Social Networks: